Kane Biotech Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kane Biotech's estimated annual revenue is currently $4.2M per year.(i)
  • Kane Biotech's estimated revenue per employee is $155,000

Employee Data

  • Kane Biotech has 27 Employees.(i)
  • Kane Biotech grew their employee count by -21% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.6M297%N/AN/A
#2
$4022.7M1064220%N/AN/A
Add Company

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Corporation has a portfolio of biotechnologies, intellectual property (58 patents and patents pending, trade secrets and trademarks) and products developed by the Corporation's own biofilm research expertise and acquired from leading research institutions. StrixNB(TM), DispersinB(R), Aledex(R), bluestem(TM), AloSera(TM), coactiv+(TM) and Kane(R) are trademarks of Kane Biotech Inc. The Corporation is listed on the TSX Venture Exchange under the symbol "KNE".

keywords:N/A

N/A

Total Funding

27

Number of Employees

$4.2M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Kane Biotech News

2022-04-06 - STEM Animal Health Awarded Veterinary Oral Health Council ...

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and...

2022-04-06 - Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific ...

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and...

2022-03-22 - Kane Biotech Announces Fourth Quarter and Full Year 2021 ...

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.3M288%N/A
#2
$6.7M2912%N/A
#3
$3.5M3030%N/A
#4
$6.9M35-8%N/A
#5
$15M376%N/A